carvedilol has been researched along with Muscular Atrophy in 1 studies
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsukawa, S | 1 |
| Kai, S | 1 |
| Seo, H | 1 |
| Suzuki, K | 1 |
| Fukuda, K | 1 |
1 other study available for carvedilol and Muscular Atrophy
| Article | Year |
|---|---|
Activation of the β-adrenergic receptor exacerbates lipopolysaccharide-induced wasting of skeletal muscle cells by increasing interleukin-6 production.
Topics: Animals; Carvedilol; CCAAT-Enhancer-Binding Protein-delta; Epinephrine; Gene Expression Regulation; | 2021 |